Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...
For centuries, the field of pathology has been defined by a single instrument: the microscope. But according to William ...
A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...
GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...
The Brighterside of News on MSN
'Fart gas' linked to memory loss and Alzheimer’s-like brain damage, study finds
Researchers at Johns Hopkins Medicine, led by Bindu Paul, an associate professor of pharmacology, psychiatry and neuroscience ...
News-Medical.Net on MSN
Two isoforms of a cellular energy sensor play distinct, opposing roles in Alzheimer's disease
A comprehensive mini-review published today after peer review in Brain Medicine by Dr. Tao Ma and colleagues at Wake Forest ...
FDA NDI Acknowledgment And Korean MFDS Approval For HB05P Muscle Health Ingredient. Akkermansia muciniphila postbiotic receives both U.S. FDA dietary supplement clearance and Korean functional ...
The IAEA profiles employees to provide insight into the variety of career paths that support the Agency’s mission of Atoms for Peace and Development and to inspire and encourage readers, particularly ...
Mice have remained the focal point for life sciences research for the past several decades. Their universality in biomedicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback